Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 5/20 | 0.58 |
| ▸ | OPRL1 | P41146 | 4/20 | 0.58 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.51 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | KDM1A | O60341 | 1/20 | 0.40 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | GRIN2B | Q13224 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17493640 | 1.00 | OPRM1 (0.58) | OPRM1OPRL1OPRD1OPRK1TDP1 | |
| Hydrochloric Acid SCHEMBL27656058 | 0.98 | OPRM1 (0.59) | OPRM1OPRL1OPRD1OPRK1TDP1 | |
| SCHEMBL4204848 | 0.94 | OPRM1 (0.60) | OPRM1OPRL1OPRD1OPRK1TDP1 | |
| SCHEMBL28914563 | 0.90 | OPRM1 (0.69) | OPRM1OPRL1OPRD1OPRK1TDP1 | |
| SCHEMBL5349572 | 0.89 | OPRM1 (0.59) | OPRM1OPRL1OPRD1OPRK1SIGMAR1 | |
| Hydrochloric Acid SCHEMBL27651798 | 0.84 | FFAR1 (0.47) | OPRM1OPRL1OPRD1OPRK1 | |
| SCHEMBL8023946 | 0.83 | OPRM1 (0.54) | OPRM1OPRL1OPRD1OPRK1TDP1 | |
| SCHEMBL4270075 | 0.82 | ESR1 (0.48) | OPRM1OPRL1TDP1SIGMAR1KMT2A | |
| SCHEMBL3106679 | 0.82 | LTA4H (0.55) | OPRM1OPRL1MAOB | |
| SCHEMBL5672427 | 0.81 | OPRM1 (0.55) | OPRM1OPRL1OPRD1OPRK1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10370767-B2 | Process for preparing alcohols by electrochemical reductive coupling | BASF SE (DE) | 2019-08-06 | — | — | US | disclosed |
| CN-106574380-B | The method for preparing alcohol by electrochemical reduction coupling | 巴斯夫欧洲公司 | 2019-05-07 | — | — | CN | disclosed |
| EP-3180459-B1 | PROCESS FOR PREPARING ALCOHOLS BY ELECTROCHEMICAL REDUCTIVE COUPLING | BASF SE (DE) | 2019-01-09 | — | — | EP | disclosed |
| US-20170233874-A1 | PROCESS FOR PREPARING ALCOHOLS BY ELECTROCHEMICAL REDUCTIVE COUPLING | BASF SE (DE) | 2017-08-17 | — | — | US | disclosed |
| EP-3180459-A1 | PROCESS FOR PREPARING ALCOHOLS BY ELECTROCHEMICAL REDUCTIVE COUPLING | BASF SE (DE) | 2017-06-21 | — | — | EP | disclosed |
| WO-2016023951-A1 | PROCESS FOR PREPARING ALCOHOLS BY ELECTROCHEMICAL REDUCTIVE COUPLING | BASF SE (DE) | 2016-02-18 | — | — | WO | disclosed |
| EP-2985364-A1 | Process for preparing alcohols by electrochemical reductive coupling | BASF SE (DE) | 2016-02-17 | — | — | EP | disclosed |
| US-7345096-B2 | Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms | WYETH (US) | 2008-03-18 | — | — | US | disclosed |
| US-7273952-B2 | Substituted C-cyclohexylmethylamine derivatives | GRUENENTHAL GMBH (DE) | 2007-09-25 | — | — | US | disclosed |
| EP-1687288-A1 | SUBSTITUTED ARYL CYCLOALKANOL DERIVATIVES AND METHODS OF THEIR USE | Wyeth (US) | 2006-08-09 | — | — | EP | disclosed |
| US-7022739-B2 | Substituted 1-aminobutan-3-ol compounds | GRUENENTHAL GMBH (DE) | 2006-04-04 | — | — | US | disclosed |
| US-6887824-B1 | Divalent lanthanide reduction catalysts | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-05-03 | — | — | US | disclosed |
| WO-2005037809-A1 | SUBSTITUTED ARYL CYCLOALKANOL DERIVATIVES AND METHODS OF THEIR USE | WYETH (US) | 2005-04-28 | — | — | WO | disclosed |
| EP-1242468-A1 | DIVALENT LANTHANIDE REDUCTION CATALYSTS | The Regents of the University of California (US) | 2002-09-25 | — | — | EP | disclosed |
| WO-2001021667-A1 | DIVALENT LANTHANIDE REDUCTION CATALYSTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2001-03-29 | — | — | WO | disclosed |
| US-5962469-A | PREVENTION OF OXIDATION TISSUE DAMAGE BY FREE RADICALS | HOECHST MARION ROUSSEL INC. (US) | 1999-10-05 | — | — | US | disclosed |
| EP-0863878-A1 | CYCLIC NITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | HOECHST MARION ROUSSEL, INC. (US) | 1998-09-16 | — | — | EP | disclosed |
| WO-1997010218-A1 | CYCLIC NITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | HOECHST MARION ROUSSEL, INC. (US) | 1997-03-20 | — | — | WO | disclosed |
| US-5124415-A | Crosslinking setting means; film-forming; for use in high frequency satellite communication bands | MATSUSHITA ELECTRIC WORKS, LTD. (JP) | 1992-06-23 | — | — | US | disclosed |
| US-4874826-A | CROSSLINKING, COPOLYMERZIATION, FORMING FILMS | MATSUSHITA ELECTRIC WORKS, LTD. (JP) | 1989-10-17 | — | — | US | disclosed |